Johnson has been determined to have intense myocarditis, which is otherwise called heart aggravation
The on-court breakdown of Florida star Keyontae Johnson might be associated with a prior positive trial of COVID-19.
Johnson has been determined to have intense myocarditis, which is otherwise called heart irritation, a condition that is accepted to infrequently result from specific instances of the infection.
The SEC Preseason Player of the Year, Johnson is relied upon to miss the rest of the period. He was delivered from the emergency clinic on Tuesday, his folks, Nika and Marrecus Johnson, said in an assertion.
“We continue to be amazed at the pace of his recovery,” they said.
“Along with so many well wishes and prayers, we’ve understandably gotten questions about the cause and extent of Keyontae’s illness. As much as everyone involved wants firm answers, the process to draw definitive conclusions continues, and we ask for patience as the medical professionals continue their work.”
“We are committed to sharing not only updates on Keyontae but also any information we think could help others. When we have that, we will share it. Until then, we continue to be grateful for the care and support Keyontae is receiving.”
Johnson tried positive for the infection in the mid year, as did a few different colleagues. He was given a heart assessment — an electrocardiogram, an echocardiogram, and a blood test that can uncover proof of cardiovascular issues — prior to getting back to exercises.
“At Florida, we do an EKG and an echo on every athlete that comes to us, so we have that on record already. So if someone gets COVID, and we repeat this cardiac workup, we are able to compare back to what they were when they came in as a freshman or transfer here. So we have a pretty good idea if there were any changes,” Florida team physician, Dr. Jay Clugston.
“There does seem to be more cases or cardiac effects from this virus than maybe we have seen from others, although, we are looking a lot more closely than we have in the past. I think all of us are cautious about it.”